Millions of people worldwide get affected by healthcare-associated infections (HAIs) while receiving health treatments. Factors such as inadequate hygiene environment conditions, poor infrastructure, insufficient equipment, absence of guidelines, and lack of knowledge regarding infection control measures increase the prevalence of HAIs. According to the 2021 National and State HAIs Progress Report released by the Centers for Disease Control and Prevention (CDC), HAIs increased significantly during 2020–2021 in a few healthcare settings. Changes in standardized infection ratio among acute care hospitals from 2020 to 2021 include a 14% increase in methicillin-resistant Staphylococcus aureus bacteremia, 12% increase in ventilator-associated events, 11% increase in surgical site infections (SSIs) following abdominal hysterectomy, 7% increase in central line-associated bloodstream infections, 5% increase in catheter-associated urinary tract infections, and 3% decrease in C. difficile infection. According to an article published by NCBI in 2022, HAIs in developing countries revealed an overall prevalence of up to 15.5%. Furthermore, in critically ill patients, the prevalence of HAIs has been reported as high as 34.1%.
The common HAIs caused by inadequate sterilization procedures are hepatitis B and C, SSIs, HIV infections, urinary and vascular catheter-associated infections, and ventilator-associated infections. Healthcare-associated infections create additional suffering for patients, increase hospital stays with high cost, and resist the function of antimicrobials. According to MDPI, in the US, HAI costs nearly US$ 10–33 billion annually, and in Europe, HAI costs exceed US$ 8.2 billion (€ 7 billion) annually.
As per the WHO, some of the important factors regarding healthcare-associated infections are mentioned below:
The facts above highlight the importance of sterilization in healthcare to prevent HAIs. Lack of sterilization in surgical instruments and reusable objects such as endoscopic devices, respiratory care devices, and hemodialysis devices leads to HAIs. Several countries are paying attention to maintain a sterilized environment and are investing resources to strengthen sterilization services owing to the widespread epidemics and increasing awareness regarding antimicrobial resistance. Thus, all these factors collectively drive the adoption of sterilization services worldwide.
The North America sterilization services market has been segmented into the US, Canada, and Mexico. The growth of the sterilization services market in the US is determined due to factors such as the easy increasing prevalence of healthcare-associated infections, and a rising number of surgical procedures is dominating the sterilization services market across the region.
The market in Canada and Mexico is expected to grow due to the increasing number of surgical procedures that are likely to severe as the growth of the sterilization services market during the forecast period.
The North America sterilization services market is segmented into mode of delivery, method, service type, end user, and country.
Based on mode of delivery, the North America sterilization services market is bifurcated into offsite sterilization services and onsite sterilization services. The offsite sterilization services segment held a larger market share in 2022.
Based on method, the North America sterilization services market is divided into ethylene oxide, chlorine dioxide, gamma ray, electron beam, autoclave steam, and others. The ethylene oxide segment held the largest market share in 2022.
Based on service type, the North America sterilization services market is segmented into contract sterilization and microbial reduction services, testing and validation services, equipment, and others. The contract sterilization and microbial reduction services segment held the largest market share in 2022.
Based on end user, the North America sterilization services market is divided into medical device companies, pharmaceutical and biopharmaceutical companies, food and beverage, hospitals and clinics, and others. The medical device companies segment held the largest market share in 2022.
Based on country, the North America sterilization services market is segmented into the US, Canada, and Mexico. The US dominated the North America sterilization services market share in 2022.
Boulder Sterilization, ClorDiSys Solutions Inc, Consolidated Sterilizer Systems, Cosmed Group, Cretex Medical, E-BEAM Services Inc, Life Science Outsourcing Inc., Midwest Sterilization Corporation, Sotera Health Company, and Steris Plc are some of the leading companies operating in the North America sterilization services market.
The North America Sterilization Services Market is valued at US$ 1,344.51 Million in 2022, it is projected to reach US$ 2,520.87 Million by 2030.
As per our report North America Sterilization Services Market, the market size is valued at US$ 1,344.51 Million in 2022, projecting it to reach US$ 2,520.87 Million by 2030. This translates to a CAGR of approximately 8.2% during the forecast period.
The North America Sterilization Services Market report typically cover these key segments-
The historic period, base year, and forecast period can vary slightly depending on the specific market research report. However, for the North America Sterilization Services Market report:
The North America Sterilization Services Market is populated by several key players, each contributing to its growth and innovation. Some of the major players include:
The North America Sterilization Services Market report is valuable for diverse stakeholders, including:
Essentially, anyone involved in or considering involvement in the North America Sterilization Services Market value chain can benefit from the information contained in a comprehensive market report.